The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)-based third line treatment: Preliminary results from a multicenter Italian study.
 
Orazio Caffo
Honoraria - Astellas Pharma; Janssen Oncology; Sanofi
 
Ugo De Giorgi
No Relationships to Disclose
 
Daniele Alesini
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Cinzia Ortega
Consulting or Advisory Role - Astellas Pharma
 
Marcello Tucci
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
 
Sarah Scagliarini
No Relationships to Disclose
 
Vittorina Zagonel
Honoraria - Bayer; Novartis; Pfizer
 
Paolo Andrea Zucali
No Relationships to Disclose
 
Franco Morelli
No Relationships to Disclose
 
Donata Sartori
No Relationships to Disclose
 
Roberto Sabbatini
No Relationships to Disclose
 
Alessandro D'Angelo
No Relationships to Disclose
 
Maddalena Donini
No Relationships to Disclose
 
Sandro Barni
No Relationships to Disclose
 
Giuseppe Procopio
Honoraria - Amgen; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Novartis
 
Zuzana Sirotova
No Relationships to Disclose
 
Teodoro Sava
No Relationships to Disclose
 
Vincenza Conteduca
No Relationships to Disclose
 
Enzo Galligioni
No Relationships to Disclose